These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


203 related items for PubMed ID: 9660

  • 1. Mepiprazole, a new psychotropic drug: effects on uptake and retention of monoamines in rat brain synaptosomes.
    Placheta P, Singer E, Kriwanek W, Hertting G.
    Psychopharmacology (Berl); 1976 Aug 17; 48(3):295-301. PubMed ID: 9660
    [Abstract] [Full Text] [Related]

  • 2. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.
    Bolden-Watson C, Richelson E.
    Life Sci; 1993 Aug 17; 52(12):1023-9. PubMed ID: 8445992
    [Abstract] [Full Text] [Related]

  • 3. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171.
    Hyttel J.
    Psychopharmacology (Berl); 1977 Mar 16; 51(3):225-33. PubMed ID: 403537
    [Abstract] [Full Text] [Related]

  • 4. Comparative effects of trazodone and tricyclic antidepressants on uptake of selected neurotransmitters by isolated rat brain synaptosomes.
    Riblet LA, Gatewood CF, Mayol RF.
    Psychopharmacology (Berl); 1979 May 25; 63(2):99-101. PubMed ID: 38478
    [Abstract] [Full Text] [Related]

  • 5. d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes.
    Raiteri M, Bertollini A, Angelini F, Levi G.
    Eur J Pharmacol; 1975 Nov 25; 34(1):189-95. PubMed ID: 1234761
    [Abstract] [Full Text] [Related]

  • 6. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake.
    Richelson E, Pfenning M.
    Eur J Pharmacol; 1984 Sep 17; 104(3-4):277-86. PubMed ID: 6499924
    [Abstract] [Full Text] [Related]

  • 7. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD, Nichols DE, Yim GK.
    Biochem Pharmacol; 1987 Jul 15; 36(14):2297-303. PubMed ID: 2886126
    [Abstract] [Full Text] [Related]

  • 8. Proceedings: The effect of mepiprazole on the uptake of norepinephrine, dopamine and serotonin into rat brain synaptosomes.
    Placheta P, Singer E, Krivanek W, Hertting G.
    Naunyn Schmiedebergs Arch Pharmacol; 1975 Jul 15; 287 Suppl():R4. PubMed ID: 1143436
    [No Abstract] [Full Text] [Related]

  • 9. The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes.
    Wells GB, Lopez MC, Tanaka JC.
    Brain Res Bull; 1999 Apr 15; 48(6):641-7. PubMed ID: 10386845
    [Abstract] [Full Text] [Related]

  • 10. Comparative actions of monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue.
    Tseng LF, Menon MK, Loh HH.
    J Pharmacol Exp Ther; 1976 May 15; 197(2):263-71. PubMed ID: 1271280
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of (3H)-dopamine uptake into rat brain synaptosomes by the new non-tricyclic antidepressants, FS32 and FS97.
    Koide T, Uyemura K.
    Eur J Pharmacol; 1980 Mar 21; 62(2-3):147-55. PubMed ID: 7379837
    [Abstract] [Full Text] [Related]

  • 12. [The influence of mepiprazol on monoamine metabolism in the rat CNS: demonstration of reduced norepinephrine activity and simultaneously enhanced serotonin and dopamine activities (author's transl)].
    Seyfried C, Nowak H, Wolf HP.
    Arzneimittelforschung; 1976 Mar 21; 26(6):1088-90. PubMed ID: 989382
    [Abstract] [Full Text] [Related]

  • 13. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine.
    Wong DT, Bymaster FP, Horng JS, Molloy BB.
    J Pharmacol Exp Ther; 1975 Jun 21; 193(3):804-11. PubMed ID: 1151730
    [Abstract] [Full Text] [Related]

  • 14. GBR 12783, a potent and selective inhibitor of dopamine uptake: biochemical studies in vivo and ex vivo.
    Bonnet JJ, Costentin J.
    Eur J Pharmacol; 1986 Feb 18; 121(2):199-209. PubMed ID: 3754516
    [Abstract] [Full Text] [Related]

  • 15. Regional changes in monoamine content and uptake of the rat brain during postnatal development.
    Nomura Y, Naitoh F, Segawa T.
    Brain Res; 1976 Jan 16; 101(2):305-15. PubMed ID: 1244975
    [Abstract] [Full Text] [Related]

  • 16. Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine.
    Raiteri M, Del Carmine R, Bertollini A, Levi G.
    Eur J Pharmacol; 1977 Jan 21; 41(2):133-43. PubMed ID: 832672
    [Abstract] [Full Text] [Related]

  • 17. Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression.
    Randrup A, Braestrup C.
    Psychopharmacology (Berl); 1977 Aug 16; 53(3):309-14. PubMed ID: 408861
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of in vitro amine uptake into rat brain synaptosomes after in vivo administration of antidepressants.
    Manias B, Taylor DA.
    Eur J Pharmacol; 1983 Nov 25; 95(3-4):305-9. PubMed ID: 6653676
    [Abstract] [Full Text] [Related]

  • 19. Differential binding of antidepressants to noradrenaline and serotonin transport sites in central nerve endings.
    Raiteri M, Del Carmine R, Cervoni AM, Levi G.
    Eur J Pharmacol; 1979 Aug 15; 57(4):407-16. PubMed ID: 488170
    [Abstract] [Full Text] [Related]

  • 20. Irreversible binding and recovery of the norepinephrine uptake system using an alkylating derivative of norepinephrine.
    Baker SP, Standifer KM, Kalberg CJ, Pitha J, Sumners C.
    J Neurochem; 1988 Apr 15; 50(4):1044-52. PubMed ID: 2894406
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.